RPB funds a new round of researchers and hits a milestone in supporting vision-related breakthroughs.
RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue
Findings indicate that retinitis pigmentosa is treatable even at advanced disease stages.
RPB is providing $500,000 to accelerate the development of treatments for Retinitis Pigmentosa (RP) -- a family of retinal diseases that progressively create extreme tunnel vision, loss of night vision and leave...
Researchers have used gene therapy to safely restore vision in three young adults with a form of retinitis pigmentosa known as Leber's congenital amaurosis (LCA), an inherited retinal disorder that reduces...
|General Info||Grants||News & Resources|